Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Chile Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20073
20083
20093
20101
20131
20141
20151
20161
20171
20181
20202
20211
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Completed10
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Pfizer4
Bristol-Myers Squibb3
GlaxoSmithKline3
Axovant Sciences Ltd.2
Eli Lilly and Company2
H. Lundbeck A/S2
ACADIA Pharmaceuticals Inc.1
Forest Laboratories1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease25
Dementia4
Psychomotor Agitation3
Cognitive Dysfunction2
Corticobasal Degeneration1
Dementia, Vascular1
Hallucinations1
Lewy Body Disease1
Lymphoma, Follicular1
Psychotic Disorders1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.